CHRS
COHERUS ONCOLOGY INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
COHERUS ONCOLOGY INC (CHRS) is held by 5 tracked hedge-fund managers, a combined reported value of ~$11.16M; the largest are Steven Cohen, Izzy Englander, Renaissance Technologies. This quarter: 1 new, 1 added, 1 trimmed. 1 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding5
Congress trades1
Price$1.39vs quarter-end-17.75%
Sectors0
This quarter's moves
Top holderSteven CohenNew1
Added1
Trimmed / sold1
Value $1.46M— of portfolio104,2002018 Q2
Value $481.0K— of portfolio36,0002017 Q3
Value $204.5K— of portfolio121,0002026 Q1
Joel GreenblattHold
Value $174.0K0.0% of portfolio10,8962021 Q4
Value $64.4K— of portfolio38,1002026 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderPUT | $1.46M | — | — |
| Izzy EnglanderCALL | $481.0K | — | — |
| Ken GriffinPUT | $204.5K | — | — |
| Joel Greenblatt | $174.0K | 0.0% | Hold |
| Ken GriffinCALL | $64.4K | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.